Mesoblast Ltd (MESO) shareholders
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| George, Gregory Joint filing with G to the Fourth Investments, LLC (10.52%) | 288,522,256 | 22.36% | 13G (passive) amendment | Mar 6, 2026 |
| Gregory George Joint filing with G to the Fourth Investments, LLC (9.92%) | 275,851,734 | 21.59% | 13G (passive) amendment | Sep 11, 2025 |
| Gueck William J. | 64,521,900 | 5.00% | 13G (passive) | Sep 12, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MESO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Morgan Stanley | 718,608 | – | $9.72M | +204,177 | 0.00% |
| BlackRock, Inc. | 664,280 | – | $8.99M | +33,425 | 0.00% |
| Susquehanna International Group, Llp | 457,744 | – | $6.19M | +71,272 | 0.00% |
| Goldman Sachs Group Inc | 395,612 | – | $5.35M | −1,603 | 0.00% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 259,700 | – | $3.51M | New | 0.00% |
| UBS Group AG | 200,053 | – | $2.71M | +67,480 | 0.00% |
| SRS Capital Advisors, Inc. | 168,022 | – | $2.27M | +143,597 | 0.02% |
| Bank Of America Corp /De/ | 100,000 | – | $1.35M | −4 | 0.00% |
| Penbrook Management LLC | 87,075 | – | $1.18M | – | 0.75% |
| M&g PLC | 59,100 | – | $827.40K | – | 0.00% |
| Quadrature Capital Ltd | 53,126 | – | $718.80K | +35,879 | 0.01% |
| LPL Financial LLC | 47,867 | – | $647.64K | −1,750 | 0.00% |
| Lazari Capital Management, Inc. | 47,421 | – | $641.61K | +1,300 | 0.20% |
| Rialto Wealth Management, LLC | 46,500 | – | $629.15K | – | 0.12% |
| Group One Trading, L.P. | 44,030 | – | $595.73K | −39,885 | 0.00% |
| Royal Bank of Canada | 44,003 | – | $595.00K | +17,737 | 0.00% |
| Two Sigma Investments, LP | 43,403 | – | $587.24K | +3,601 | 0.00% |
| Geode Capital Management, LLC | 33,747 | – | $456.60K | – | 0.00% |
| Jane Street Group, LLC | 33,152 | – | $448.55K | −65,634 | 0.00% |
| &partners | 27,567 | – | $372.98K | +621 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 71 | 4M | 9 / 24 | 20 / 6 | 1M | 0M |
| Q1 2026 | 69 | 3M | 9 / 25 | 17 / 13 | 0M | 1M |
| Q4 2025 | 74 | 4M | 14 / 24 | 21 / 7 | 1M | 0M |
| Q3 2025 | 67 | 4M | 13 / 21 | 19 / 17 | 1M | 1M |
| Q2 2025 | 71 | 4M | 15 / 19 | 21 / 11 | 1M | 1M |
| Q1 2025 | 68 | 4M | 17 / 24 | 15 / 10 | 2M | 1M |
| Q4 2024 | 61 | 3M | 26 / 21 | 6 / 8 | 2M | 0M |
| Q3 2024 | 43 | 2M | 10 / 13 | 11 / 4 | 0M | 0M |
| Q2 2024 | 39 | 1M | 17 / 12 | 4 / 3 | 1M | 0M |
| Q1 2024 | 26 | 1M | 24 / 1 | 1 / 0 | 1M | 0M |
| Q4 2023 | 2 | 0M | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
9 funds held MESO in Q2 2026, 98% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MESO | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Biotechnology ETF | 495,405 | – | $6.70M | 0.07% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 33,747 | – | $519.70K | 0.00% | May 31, 2026 |
| Steward Values Enhanced International Fund | 6,507 | – | $92.20K | 0.03% | Jul 31, 2026 |
| ActivePassive International Equity ETF | 6,319 | – | $97.31K | 0.01% | May 31, 2026 |
| Invesco Nasdaq Biotechnology ETF | 2,767 | – | $42.61K | 0.06% | May 31, 2026 |
| ProShares Ultra Nasdaq Biotechnology | 1,934 | – | $29.78K | 0.04% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -100 | – | -$1.35K | -0.00% | Jun 30, 2026 |
| Multi-Manager Directional Alternative Strategies Fund | -6,514 | – | -$92.30K | -0.03% | Jul 31, 2026 |
| Boston Partners Long/Short Research Fund | -28,324 | – | -$436.19K | -0.07% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Silviu Itescu | CEO and Managing Director | 78,958,928 | Apr 1, 2026 |
| Eric Allen Rose | Chief Medical Officer,Director | 714,720 | Mar 18, 2026 |
| James Michael Obrien | Chief Financial Officer | – | Jul 9, 2026 |
| Lynette Elizabeth Cobley | Director | 63,000 | Apr 29, 2026 |
| Gregory George | Director, 10% owner | 162,154,002 | Apr 13, 2026 |
| William Murray Burns | Director | 226,250 | Apr 1, 2026 |
| Philip James Facchina | Director | 123,220 | Mar 18, 2026 |
| Jane Catherine Bell | Director | 622,492 | Mar 18, 2026 |
| Philip R. Krause | Director | 287,500 | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gregory George Director, 10% owner | Apr 10, 2026 | Buy | +2,324,072 | $1.48 | $3.44M | 8,324,072 |
| Gregory George Director, 10% owner | Apr 10, 2026 | Buy | +2,324,072 | $1.48 | $3.44M | 8,324,072 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.43 | $14.30K | 13,536,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +20,000 | $1.43 | $28.60K | 13,526,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +4,760 | $1.44 | $6.85K | 13,506,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +5,240 | $1.43 | $7.49K | 13,541,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +886,890 | $1.43 | $1.27M | 12,886,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +105,000 | $1.46 | $153.30K | 12,991,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +500,000 | $1.44 | $720.00K | 13,491,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.44 | $14.40K | 13,501,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.41 | $14.10K | 13,586,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.43 | $14.30K | 13,576,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.43 | $14.30K | 13,566,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +5,000 | $1.43 | $7.15K | 13,556,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $1.43 | $14.30K | 13,551,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.40 | $144.00K | 13,501,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +4,760 | $14.40 | $68.54K | 13,506,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +20,000 | $14.30 | $286.00K | 13,526,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.30 | $143.00K | 13,536,650 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +5,240 | $14.25 | $74.67K | 13,541,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.25 | $142.50K | 13,551,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +5,000 | $14.30 | $71.50K | 13,556,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.30 | $143.00K | 13,566,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.30 | $143.00K | 13,576,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +500,000 | $14.39 | $7.20M | 13,491,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +500,000 | $14.39 | $7.20M | 13,491,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +886,890 | $1.43 | $1.27M | 12,886,890 |
| Gregory George Director, 10% owner | Apr 9, 2026 | Buy | +10,000 | $14.10 | $141.00K | 13,586,890 |
| Gregory George Director, 10% owner | Apr 4, 2026 | Buy | +4,000,000 | $1.42 | $5.68M | 12,000,000 |
| Gregory George Director, 10% owner | Apr 4, 2026 | Buy | +4,000,000 | $1.42 | $5.68M | 12,000,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Mesoblast's stock actually held short. Settlement fails (shares not delivered on time) peaked at 60,075 shares on Aug 31, 2026 over the last 90 days.
See a number that looks wrong?